Atricure Inc (ATRC) financials

NASDAQ · Health Care

$61.25 -1.97% Close Oct 30, 2026 Live

Atricure revenue and earnings by year

Atricure's revenue was $535 million in the fiscal year to December 31, 2025, up 14.9% from the year before. Net income was -$11.4 million, -2.1% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 14.7% a year on average.

RevenueNet income
$0$200M$400M
2016201720182019202020212022202320242025

Fiscal years, each labelled by the calendar year it ended in.

Income statement, the last 10 fiscal years

In millions of US dollars except per-share figures. Each column is a fiscal year, named by the month it ended.
Fiscal year toDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
Revenue535465399330274207231202175155
Revenue growth14.9%16.5%20.8%20.4%32.8%-10.5%14.5%15.4%12.6%—
Gross profit401348300246206149170147126111
Gross margin75.0%74.7%75.2%74.4%75.0%72.3%73.8%73.0%72.2%71.6%
Operating income-9-40-27-43-130-45-38-17-25-31
Operating margin-1.8%-8.6%-6.7%-12.9%-47.2%-21.6%-16.5%-8.5%-14.3%-20.1%
Net income-11-45-30-4650-48-35-21-27-33
Net margin-2.1%-9.6%-7.6%-14.1%18.3%-23.3%-15.2%-10.5%-15.4%-21.5%
Diluted EPS-$0.24-$0.95-$0.66-$1.02$1.09-$1.16-$0.94-$0.63-$0.83-$1.05
Free cash flow481-8-39-24-25-28-10-15-23

Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open ATRC in Markets.

See also: ATRC valuation and P/E history · ATRC returns

No forecast, no recommendation. This page describes Atricure Inc from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.